Viewing data from:

MORPHINE SULFATE

ANDA

MORPHINE SULFATE | A076438 | SPECGX LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MS CONTIN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$2.05

per ea

Lowest NADAC/Unit

$0.8650

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00406832001MORPHINE SULF ER 200 MG TABLET	$2.05	EA	Generic	—	2026-06-17
00406839001MORPHINE SULF ER 100 MG TABLET	$0.8650	EA	Generic	—	2026-06-17
00406839023MORPHINE SULF ER 100 MG TABLET	$0.8650	EA	Generic	—	2026-06-17
00406839062MORPHINE SULF ER 100 MG TABLET	$0.8650	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$60.29

Highest Price

$293.31

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00406-8390-01MORPHINE SO4 100MG ER TAB	$60.29	FSS	SpecGx LLC	09/14/2027
00406-8390-62MORPHINE SO4 100MG ER TAB	$293.31	FSS	SpecGx LLC	09/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs6 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SPECGX LLCMORPHINE SULFATE

DMF 58571985

NORAMCO LLCMORPHINE SULFATE

DMF 69671987

VERANOVA LPMORPHINE SULFATE USP

DMF 215882008

NORAMCO LLCMORPHINE SULFATE, USP

DMF 293172015

PENICK CORPInactiveMORPHINE SULFATE

DMF 66801986

MACFARLAN SMITH LTDInactiveMORPHINE SULFATE

DMF 83281989

MALLINCKRODT INCInactiveMORPHINE SULFATE INJECTION USP

DMF 115291995

ELAN PHARMA LTDInactiveMORPHINE SULFATE

DMF 128081997

SIEGFRIED USA LLCInactiveMORPHINE SULFATE USP

DMF 196932006

CODY LABORATORIES INCInactiveMORPHINE SULFATE, USP

DMF 280402014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 100MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Jul 3, 2003

No patent or exclusivity listings for this strength.

#002 — 200MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Jul 3, 2003